Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-25 8:48 pm Purchase |
2024-07-15 | 13G | CASI Pharmaceuticals, Inc. CASI |
Venrock Healthcare Capital Partners III L.P. | 1,507,040 9.990% |
1,507,040 (New Position) |
Filing |